chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my second Pfizer booster for COVID-19 on 5/26/2022. On 8/31/2022, I felt sluggish, worn out, and apathetic. I felt weak and exhausted. I normally do long walks for exercise, but I stopped my walk early that day on account of my fatigue. I came home and ate, but I didn't have much of an appetite. I rested and didn't do much for the rest of the day. As the day progressed, I began to feel like I was getting a severe cold. I began to have body aches and general malaise. When I was in bed that night, I began to have chills. When I woke up on 9/1/2022, I had chills and laryngitis. I suspected that I had COVID-19, so I took a home test and got a positive result. I then went to the clinic and I was examined by a PA in the drive-thru. He confirmed that I had COVID-19 when he saw my home test and prescribed me PAXLOVID, which I began taking that day. I then went home and went to bed. I had a temperature of 101, chills, body aches, runny nose, nasal congestion, and complete loss of taste and smell. I also experienced appetite loss, weakness, and extreme fatigue. With the PAXLOVID, I got better. I noticed an improvement as soon as I took the second pill. Each day afterwards, I got progressively better. On 9/4/2022 or 9/5/2022, I took another test and got another positive result. On 9/6/2022 or 9/7/2022, I took another test and finally got a negative result. I felt well at that point, so I returned to my normal activities. On 9/9/2022 or 9/10/2022, I began to have the early symptoms of COVID-19 again. I took a test and got another positive result; I had a rebound. I emailed my doctor and informed him of the situation; he advised me that I had a breakthrough and that I should lay low for a few days. If I developed a fever or my symptoms worsened, I was to call him immediately. On 9/13/2022 or 9/14/2022, I took another test and got another negative result. I then went on with my life. At the time of this writing, I still have not completely regained my senses of taste and smell. Other than that, I don't have any residual issues left over from the COVID-19. I used my oximeter religiously during my illness, and it never went below 94%.
Pt developed severe redness and some swelling to injection site; had to consult her doctor. She complained about itching and pain in vaccination site, started 2 days after vaccination, see doctor report.
Swollen legs; Headaches; Mild diarrhea; Really fast heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Mild diarrhea), PERIPHERAL SWELLING (Swollen legs), PALPITATIONS (Really fast heartbeat) and HEADACHE (Headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DIARRHOEA (Mild diarrhea) and PALPITATIONS (Really fast heartbeat). On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen legs) and HEADACHE (Headaches). At the time of the report, DIARRHOEA (Mild diarrhea), PERIPHERAL SWELLING (Swollen legs), PALPITATIONS (Really fast heartbeat) and HEADACHE (Headaches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Highly likely mother received infant/toddler Pfizer monovalent vaccine versus receiving intended Adult Pfizer bivalent vaccine.
Physician drew titers to check patient's immunity from the recent community exposure to chicken pox/titers were negative for varicella; This spontaneous report was received from a physician and refers to a 12 year old male patient. The patient's medical history included an exposure to chicken pox from his community. His concurrent conditions and concomitant medications were not reported. The patient's vaccination history was unknown.  On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot #, expiration date, dose, route and frequency were not reported) for prophylaxis. On an unknown date, a few days post vaccination, the reporting physician drew titers to check patient's immunity from the recent community exposure to chicken pox (and not due to recent vaccination) and then, the patient's titers were negative for varicella. It was also reported that "no adverse effects were reported" (discrepant information). At the reporting time, the outcome of varicella virus test negative was not reported. The reporter did not provide a causal relationship between the event and varicella virus vaccine live (oka/merck)(VARIVAX).
VR received her 2nd dose of COVID and was walked to the observation area where she reported that she was experiencing palpitations.  I had the VR lay in the cot.  VR reported that she had a hx of paroxysmal A-fib and takes eliquis.  VR reported only chest palpitations at this time.  I took her VS which was HR 100 (Afib), 99% on RA, 160/95 BP, & 22 RR.  After 2 minutes, the VR began complaining of chest pain as she clutched her chest.  At 1116 hours, EMS was called for her chest pain.  The VR was given 324mg ASA PO.  VR then began complaining of pain radiating to her back. EMS arrived and VR was taken to hospital for further evaluation. VSS and VR was A&O x 3 at the time of transport.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (administered expired dose) and product storage error (vial refrigerated Feb 7, 2022; administered Mar 29, 2022) in a 24-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 083J21A) for COVID-19 immunization. No medical history reported. On Mar 29, 2022, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 29, 2022, patient administered expired product (administered expired dose). On an unknown date, patient experienced product storage error (vial refrigerated Feb 7, 2022; administered Mar 29, 2022). At the time of the report, administered expired product (administered expired dose) and product storage error (vial refrigerated Feb 7, 2022; administered Mar 29, 2022) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Vial initially stored in refrigerator Feb 7, 2022, did not undergo any temperature excursions. This case linked to MOD-2022-584679 (patient link).
Arm soreness  1-3 days post vaccine flu like symptoms 4-7 days post vaccine Severe back pain 4-10 days post vaccine Death 11 days post vaccine
Severe headache, chills, fever >101, left eye twitching, tingling along nerve pathway, right arm swelling beyond site of injection from site down to elbow, with 2 small blisters at edge of site.
I received the Booster Pfizer at 1 p.m. 12/9/21.  Later that evening, below eyes were irritated.  On 12/10/21 5:oo a.m., below left eye, irritation, red, swollen and discomfort.  Two benadryl at 9:30 a.m.
Fever, malaise 2 days; arm pain at site of injection --continues at time of report May 19, 2018.
After the shot a few hours later my arm start to hurt and feel like pins and needles. My hand feels like pins and needles which comes and goes. Each day after my hurt hurts more and more like I was hit with a hammer. I have headache and dizziness and can?t sleep.
Got the vaccine and got shingles/Suspected vaccination failure; Got the vaccine and got shingles on my face a year later; worst pain I have ever experienced; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 30-July-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the vaccine and got shingles on his/her face a year later, worst pain the patient ever had experienced in his/her life. The patient stated that child birth was not that painful. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
On that morning of 03/13/2023, I woke up feeling nauseated. I was just nauseated all day and wasn't feeling well. The next morning on the 14th, the nausea was gone but I had a headache. I felt ill all over. I had COVID-19 before right after Christmas 2022 and I knew what the symptoms were like, so I gave myself a test and it was positive. I called my PA and talked to her. We decided not to get PAXLOVID again because the symptoms didn't seem to be that bad. We decided to skip the PAXLOVID. By the next day on the 15th, I felt better. I basically had symptoms for only 2 days.
Information has been received from a nurse concerning an adult female employee of the practice who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (lot# not reported). Subsequently, she was diagnosed with chickenpox. At the time of this report, the employee had recovered. No further information is available.
The patient have seasonal allergies. His throat was itchy prior to vaccination and he got worse after vaccine administration. He drunk water, and took Benadryl. Pulse 78, respiration 18, spo2 98%, bp 112/76. At 11:42, he felt better, symptoms resolved and went home
May have been / an allergic reaction / Nausea; May have been / an allergic reaction / Fever; May have been / an allergic reaction / Small rash; May have been / an allergic reaction / did not feel well; Allergic reaction; She has not had her second dose; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced nausea, fever, rash, feeling unwell, allergic reaction and incomplete course of vaccination. On an unknown date, the outcome of the nausea, fever, rash and feeling unwell were recovered/resolved and the outcome of the allergic reaction and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the nausea, fever, rash, feeling unwell and allergic reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for the 2nd dose. The patient received the 1st dose of Shingrix on left arm. The physician thought her symptoms after the first dose, might have been the result of an allergic reaction. The did not feel well, had nausea, a fever and a small rash. Patient did not remember the location of rash. Till the time of reporting patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Case number PHEH2014US022645 is an initial spontaneous report received from a nurse on 07 Nov 2014. This report refers to a 3 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with an intramuscular dose of FLUVIRIN (batch number: 1412121) from a multi dose vial (MDV) on 07 Nov 2014. No adverse events were reported following the inadvertent administration.
8/20/12- Received Imm. 8/21/12 3:00 AM work up with throbbing, hot, sore (L) arm at injection site - continued to lump at site - 8/22 - reddened area moved to elbow, hotter arm, lump soreness continues.
PAIN AND EDEMA AT SITE OF INJECTION LEFT ARM WITH DECREASED RANGE OF MOTION LEFT ARM RIB CAGE PAIN ON INSPIRATION MUSCLE PAIN RIGHT AND LEFT THIGHS, WORSENING UPON AMBULATION MUSCLE PAIN AND TINGLING RIGHT UPPER EXTREMITY AND BACK
I was incoherent for 3 day s weak, could not remember what I was doing
Loss of taste; Loss of smell; Injection arm pain; Injection site swelling; Injection site redness; Headache; General exhaustion; Fever low grade, 101 max; Hand,finger, arm numbness; Nasal congestion; This spontaneous case was reported by a non-health professional and describes the occurrence of HYPOAESTHESIA (Hand,finger, arm numbness), NASAL CONGESTION (Nasal congestion), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and VACCINATION SITE PAIN (Injection arm pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Dec-2020, the patient experienced HYPOAESTHESIA (Hand,finger, arm numbness), NASAL CONGESTION (Nasal congestion), VACCINATION SITE PAIN (Injection arm pain), VACCINATION SITE SWELLING (Injection site swelling), VACCINATION SITE ERYTHEMA (Injection site redness), HEADACHE (Headache), FATIGUE (General exhaustion) and PYREXIA (Fever low grade, 101 max). On 26-Dec-2020, the patient experienced AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). On 25-Dec-2020, FATIGUE (General exhaustion) and PYREXIA (Fever low grade, 101 max) had resolved. On 26-Dec-2020, HYPOAESTHESIA (Hand,finger, arm numbness), VACCINATION SITE PAIN (Injection arm pain), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site redness) had resolved. On 30-Dec-2020, NASAL CONGESTION (Nasal congestion) and HEADACHE (Headache) had resolved. At the time of the report, AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Dec-2020, SARS-CoV-2 test: negative (Negative) Negative. On 29-Dec-2020, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Action taken with mRNA-1273 in response to the events was not reported.   No relevant concomitant medications were reported. No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the events loss of taste and smell is unlikely related to mRNA-1273. Further information has been requested.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the events loss of taste and smell is unlikely related to mRNA-1273. Further information has been requested.
Information has been received from a physician concerning a 12 month old patient who on 08-APR-2010 was vaccinated with the first dose of VARIVAX (Merck) (lot number not provided). The physician reported that one week after vaccination on approximately 15-APR-2010 the patient experienced a 2 cm rash with vesicles. At the time of the report the patient had recovered. The patient did not seek medical attention. Additional information has been requested.
This medically confirmed spontaneous report (initial receipt: 01-Oct-2012) concerns a 23-year-old female patient, who had a pertinent medical history of Behcet's Syndrome and asthma. She was allergic to DAPSONE. Concomitant medications included prednisolone, cyclosporine, paracetamol/codeine combination, procaterol hydrochloride, celecoxib, tramadol, beclomethasone diproprionate and omeprazole. On 26-Sep-2012 the patient received AFLURIA (batch number: P58507) in the left arm. On the same date the patient also received PNEUMOVAX 23 (batch number: 0709AE) injection in right deltoid intramuscularly for vaccination. She received AFLURIA in the opposite arm from PNEUMOVAX 23 vaccination. She also had a previous vaccination with PNEUMOVAX 23 (date unspecified). On 27-Sep-2012 the patient had onset of high fever, pain in the joints and vomiting. On 28-Sep-2012 she went to the Emergency Room and was hospitalised on the same day for treatment. The event outcome was not recovered. On 01-Oct-2012 the nurse considered event as serious (due to hospitalisation).
Pt received chicken pox (varicella ) vaccine on 03/12/1997, but has chicken pox on 2/10/2004. Treated with - Zovirax orall (200mg/ 5ul) 11am- QID X5 day/ Alanax
Pt reported that 5 min p/recvd Hep-B vax devel n&v, fever, h/a, & SOB duration of sx 2 hrs;
METALLIC TASTE IN MOUTH WITHIN 20 MINS OF RECEIVING THE VACCINE.
3A noticed blood in the stool on 5/17/2011 and then a couple of times this A.M. 97.6 Ax. Pt had an appt at clinic.
12 hours after vaccine fever chills. Vomited every 30 minutes for over 5 hours.  48 hours later still fatigued and very nauseous.
Arm pain and slight swelling within hour or injection but resolved within 24hrs.  About 4.5 days later on Sunday (3/28) night I started feeling sharp, strange pains in my right arm pit.  By Monday morning the arm pit pain had extended under my arm and surrounding arm pit area.  Later Monday right arm ached all the way down to my wrist and hand.  Tuesday my right arm near and around the injection site swelled immensely, significant muscle pain (in addition to the aching down the arm) and joint soreness.  I also developed hot, splotchy rash like reaction that itched slightly.  Pain and discomfort was enough to disrupt sleep and interfere with normal daily activities.
On 6/29 cough, congestion, headache and fever. 6/30 COVID 19 test PCR. July 1st, test results positive and symptoms became more severe, especially headache. Called doctor and got a prescription for PAXLOVID. Symptoms improving and mostly over.
I started having a sore throat and a runny nose. I also experienced a lot of coughing with half of the time being productive, the other half being unproductive. I did not have a fever. Then I experienced a stuffy nose. My asthma kicked in, so I was told to use my Nebulizer. I was also given a course of Prednisone along with Benzonatate and an additional antibiotic.
flu like symptoms; was in bed; This case was reported by a pharmacist via sales rep and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms and mobility decreased. On an unknown date, the outcome of the influenza-like symptoms was unknown and the outcome of the mobility decreased was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms and mobility decreased to be related to Shingrix.  Additional details provided were as follows: Age at vaccination was not reported. The reporter administered Shingrix to the patient (co-worker) and experienced flu like symptoms and was in bed the entire day the next day. VAERS details were captured. The reporter denied to follow-up.
Chills/Shaking,  102 fever, swollen lymph nodes under chin, nausea, tiredness
Per caller, she is not aware if either patient had any symptoms after administration. No additional AE's/PQC's reported.; Per caller, excursion occurred on 8/20/2021. Caller notes, the V ARlV AX has been administered to (2) patients.; This spontaneous report has been received from a nurse, concerning to a patient of unknown gender and age. No information was provided regarding the patients' pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies.  On 20-AUG-2021, the virus vaccine live (oka/merck) (VARIVAX) was improperly stored at -14.2 degrees Celsius (C) for a timeframe of 16 minutes (min); there were not previous temperature excursions reported (product storage error).   On 20-AUG-2021, the patient was vaccinated with one (1) varicella virus vaccine live (oka/merck) (VARIVAX) (lot number T028306 has been verified to be a valid lot number, expiration date reported and established as 20-AUG-2022) as prophylaxis (exact dose, dose number, vaccination scheme frequency, route of administration, and anatomical location of vaccination were not reported), which was possibly improperly stored as the nurse did not know if the temperature excursion occurred before the administration or as a result of it. The reporter was not aware if the patient had any symptoms after administration; no additional adverse events (AE) reported (no adverse event).  This is one of two reports received from the same reporter; Sender's Comments:  US-009507513-2109USA005042:
Patient hospitalized for acute hematogenous osteomyelitis within 6 weeks of receiving COVID vaccination.
positive result for Hepatitis A, Food Poisoning, and Mononucleosis; positive result for Hepatitis A, Food Poisoning, and Mononucleosis; positive result for Hepatitis A, Food Poisoning, and Mononucleosis; This is a spontaneous case report received from a contactable consumer(patient) via Pfizer-sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 09Feb2021 as a single dose for COVID-19 immunisation. Medical history included kidney transplant. The patient's concomitant medications were not reported. On unspecified date, the patient experienced hepatitis A virus test positive, food poisoning . He questioned if it was wrong of him to get vaccinated and get bloodwork done on the next day and if the vaccine may have caused this. The patient underwent lab tests and procedures which included blood test with unknown result, hepatitis A virus test positive. The clinical outcome of the events was unknown. Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
headache, fatigue, chills, nausea, muscle pain, fever Narrative:  Other Relevant History:
delayed onset of erythema, warmth, discomfort (~ day 10 after injection)
Complaints of redness and swelling at injection site that extended 5 inches up towards R shoulder. Also, complaint of fever at site. Denies hardness. Phone call with complaints two days after injection by client's mother. Mother states primary physician notified who advised to report to clinic where injection given. Mother denies private doctor seeing injection site.
pt recv vax 15JUN98 & same day pt devel hives;pt was treated w/DPH & colloidal oatmeal (aveeno bath);
Patient admitted 9/29/21 with concern for autoimmune encephalitis. Per wife pt first developed abnormal taste and sense of smell in February after receiving his second dose of Moderna vaccine. Symptoms were so severe that would cause nausea and decreased oral intake. He was also feeling fatigue and at times had gait imbalance. He was evaluated by ENT at that time. In May while they were at a camping trip he has a grand mal seizure. Received moderna vaccine on 1/31/21 and 2/27/21.  Unclear if these symptoms are related to vaccine.  Per note from 8/27/21: "The MRI appearance and significant resolution over 2 - 3 months is most consistent with an autoimmune encephalitis, particularly given that all of his symptoms began shortly after vaccination (the Covid vaccination)."